Literature DB >> 10684323

Carbohydrate-deficient glycoprotein syndromes.

N Gordon1.   

Abstract

Four types of carbohydrate-deficient glycoprotein syndrome have been described, and the cause of two of them has been found. The symptoms and signs of these syndromes are described, with variations that occur at different ages. The commonest is type Ia with an autosomal recessive form of inheritance, and the gene responsible has been mapped to 16p. The typical pathology is atrophy of the cerebellum and brainstem, sometimes also involving the cortex, although both the pathology and the biochemical deficiencies vary between different types of syndrome. The diagnosis depends firstly on recognising the clinical features, including the presence of complications such as thyroid disorders. Then biochemical tests can be carried out, especially chromatographic carbohydrate-deficient transferrin assay and isoelectric focusing of serum transferrin. The prognosis depends on the complications, renal, hepatic, and cardiac, but affected children will be severely handicapped. Therefore treatment consists mainly of coping with the complications, and supporting the child and the family. Oral infusion of mannose can be effective in type Ib disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684323      PMCID: PMC1741531          DOI: 10.1136/pmj.76.893.145

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  31 in total

1.  Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency).

Authors:  R Barone; H Carchon; E Jansen; L Pavone; A Fiumara; N U Bosshard; R Gitzelmann; J Jaeken
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

2.  Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation.

Authors:  J Jaeken; G Matthijs; J M Saudubray; C Dionisi-Vici; E Bertini; P de Lonlay; H Henri; H Carchon; E Schollen; E Van Schaftingen
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Disialotransferrin developmental deficiency syndrome.

Authors:  B Kristiansson; M Andersson; B Tonnby; B Hagberg
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

4.  Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency).

Authors:  R Barone; L Pavone; A Fiumara; R Bianchini; J Jaeken
Journal:  Brain Dev       Date:  1999-06       Impact factor: 1.961

5.  Missense mutations in the phosphomannomutase 2 gene of two Japanese siblings with carbohydrate-deficient glycoprotein syndrome type I.

Authors:  K Mizugishi; K Yamanaka; K Kuwajima; I Yuasa; K Shigemoto; I Kondo
Journal:  Brain Dev       Date:  1999-06       Impact factor: 1.961

6.  Neurophysiological findings in a case of carbohydrate-deficient glycoprotein (CDG) syndrome type I with phosphomannomutase deficiency.

Authors:  E Veneselli; R Biancheri; M Di Rocco; S Tortorelli
Journal:  Eur J Paediatr Neurol       Date:  1998       Impact factor: 3.140

7.  A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.

Authors:  T J de Koning; L Dorland; O P van Diggelen; A M Boonman; G J de Jong; W L van Noort; J De Schryver; M Duran; I E van den Berg; G J Gerwig; R Berger; B T Poll-The
Journal:  Biochem Biophys Res Commun       Date:  1998-04-07       Impact factor: 3.575

8.  Carbohydrate-deficient glycoprotein syndrome type I: a new cause of dysostosis multiplex.

Authors:  C Garel; C Baumann; M Besnard; H Ogier; J Jaeken; M Hassan
Journal:  Skeletal Radiol       Date:  1998-01       Impact factor: 2.199

9.  Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.

Authors:  R Niehues; M Hasilik; G Alton; C Körner; M Schiebe-Sukumar; H G Koch; K P Zimmer; R Wu; E Harms; K Reiter; K von Figura; H H Freeze; H K Harms; T Marquardt
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

10.  Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities.

Authors:  M J Acarregui; T N George; W J Rhead
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

View more
  3 in total

1.  Genetic networks in the mouse retina: growth associated protein 43 and phosphatase tensin homolog network.

Authors:  Natalie E Freeman; Justin P Templeton; William E Orr; Lu Lu; Robert W Williams; Eldon E Geisert
Journal:  Mol Vis       Date:  2011-05-25       Impact factor: 2.367

2.  Ophthalmological and electrophysiological findings in monozygotic twin sisters with phosphomannomutase 2 deficiency (PMM2-CDG) over a period of 37 years.

Authors:  Ines Van Hees; Jaak Jaeken; Wouter Meersseman; Ingele Casteels
Journal:  GMS Ophthalmol Cases       Date:  2019-11-20

Review 3.  UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.

Authors:  Maria E Terlizzi; Giorgio Gribaudo; Massimo E Maffei
Journal:  Front Microbiol       Date:  2017-08-15       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.